CN107432472B - 一种治疗腹泻的组合物及其应用 - Google Patents
一种治疗腹泻的组合物及其应用 Download PDFInfo
- Publication number
- CN107432472B CN107432472B CN201710743148.8A CN201710743148A CN107432472B CN 107432472 B CN107432472 B CN 107432472B CN 201710743148 A CN201710743148 A CN 201710743148A CN 107432472 B CN107432472 B CN 107432472B
- Authority
- CN
- China
- Prior art keywords
- parts
- powder
- diarrhea
- seed
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 206010012735 Diarrhoea Diseases 0.000 title claims abstract description 43
- 239000000203 mixture Substances 0.000 title claims abstract description 22
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims abstract description 20
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 20
- 235000008434 ginseng Nutrition 0.000 claims abstract description 20
- 244000268590 Euryale ferox Species 0.000 claims abstract description 19
- 239000008187 granular material Substances 0.000 claims abstract description 19
- 235000006487 Euryale ferox Nutrition 0.000 claims abstract description 18
- 244000077995 Coix lacryma jobi Species 0.000 claims abstract description 17
- 240000002853 Nelumbo nucifera Species 0.000 claims abstract description 17
- 235000006508 Nelumbo nucifera Nutrition 0.000 claims abstract description 17
- 235000006510 Nelumbo pentapetala Nutrition 0.000 claims abstract description 17
- 244000274050 Platycodon grandiflorum Species 0.000 claims abstract description 17
- 244000197580 Poria cocos Species 0.000 claims abstract description 16
- 235000008599 Poria cocos Nutrition 0.000 claims abstract description 16
- 235000010580 Psophocarpus tetragonolobus Nutrition 0.000 claims abstract description 16
- 241000046198 Triteleia hyacinthina Species 0.000 claims abstract description 16
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims abstract description 15
- 235000006753 Platycodon grandiflorum Nutrition 0.000 claims abstract description 15
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 claims abstract description 15
- 244000303040 Glycyrrhiza glabra Species 0.000 claims abstract description 14
- 235000011477 liquorice Nutrition 0.000 claims abstract description 14
- 235000002722 Dioscorea batatas Nutrition 0.000 claims abstract description 13
- 235000006536 Dioscorea esculenta Nutrition 0.000 claims abstract description 13
- 240000001811 Dioscorea oppositifolia Species 0.000 claims abstract description 13
- 235000003416 Dioscorea oppositifolia Nutrition 0.000 claims abstract description 13
- 244000131316 Panax pseudoginseng Species 0.000 claims abstract 3
- 239000000843 powder Substances 0.000 claims description 47
- DLRVVLDZNNYCBX-RTPHMHGBSA-N isomaltose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)C(O)O1 DLRVVLDZNNYCBX-RTPHMHGBSA-N 0.000 claims description 13
- 239000011230 binding agent Substances 0.000 claims description 11
- 210000000582 semen Anatomy 0.000 claims description 8
- 235000013406 prebiotics Nutrition 0.000 claims description 7
- 238000005303 weighing Methods 0.000 claims description 7
- 238000001035 drying Methods 0.000 claims description 6
- 238000004806 packaging method and process Methods 0.000 claims description 5
- 238000002360 preparation method Methods 0.000 claims description 4
- 239000002994 raw material Substances 0.000 claims description 4
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims description 3
- 240000008669 Hedera helix Species 0.000 claims description 2
- 238000007873 sieving Methods 0.000 claims description 2
- 238000009472 formulation Methods 0.000 claims 1
- 238000000034 method Methods 0.000 claims 1
- 239000000825 pharmaceutical preparation Substances 0.000 claims 1
- 210000000952 spleen Anatomy 0.000 abstract description 20
- 230000000694 effects Effects 0.000 abstract description 14
- 239000003814 drug Substances 0.000 abstract description 10
- 210000002784 stomach Anatomy 0.000 abstract description 8
- 235000013402 health food Nutrition 0.000 abstract description 5
- 235000013376 functional food Nutrition 0.000 abstract description 4
- 235000005911 diet Nutrition 0.000 abstract description 3
- 230000037213 diet Effects 0.000 abstract description 3
- 230000007661 gastrointestinal function Effects 0.000 abstract description 3
- 230000001788 irregular Effects 0.000 abstract description 3
- 231100000957 no side effect Toxicity 0.000 abstract description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 2
- 239000003205 fragrance Substances 0.000 abstract description 2
- 239000000284 extract Substances 0.000 description 24
- 241000208340 Araliaceae Species 0.000 description 17
- 238000005516 engineering process Methods 0.000 description 12
- 229930014626 natural product Natural products 0.000 description 12
- 230000000052 comparative effect Effects 0.000 description 8
- 210000004072 lung Anatomy 0.000 description 6
- 235000009508 confectionery Nutrition 0.000 description 5
- 230000007812 deficiency Effects 0.000 description 5
- 238000002474 experimental method Methods 0.000 description 5
- 210000003734 kidney Anatomy 0.000 description 5
- 239000004376 Sucralose Substances 0.000 description 4
- 235000013305 food Nutrition 0.000 description 4
- 238000005507 spraying Methods 0.000 description 4
- BAQAVOSOZGMPRM-QBMZZYIRSA-N sucralose Chemical compound O[C@@H]1[C@@H](O)[C@@H](Cl)[C@@H](CO)O[C@@H]1O[C@@]1(CCl)[C@@H](O)[C@H](O)[C@@H](CCl)O1 BAQAVOSOZGMPRM-QBMZZYIRSA-N 0.000 description 4
- 235000019408 sucralose Nutrition 0.000 description 4
- 235000004879 dioscorea Nutrition 0.000 description 3
- 239000002552 dosage form Substances 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 210000002216 heart Anatomy 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 230000007935 neutral effect Effects 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- 208000035143 Bacterial infection Diseases 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 241000202807 Glycyrrhiza Species 0.000 description 2
- 206010033557 Palpitations Diseases 0.000 description 2
- 235000006751 Platycodon Nutrition 0.000 description 2
- 206010047700 Vomiting Diseases 0.000 description 2
- 230000001154 acute effect Effects 0.000 description 2
- 208000022531 anorexia Diseases 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 229940088710 antibiotic agent Drugs 0.000 description 2
- 208000022362 bacterial infectious disease Diseases 0.000 description 2
- 229940069765 bean extract Drugs 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- 206010061428 decreased appetite Diseases 0.000 description 2
- 208000002173 dizziness Diseases 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 201000000117 functional diarrhea Diseases 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 235000012054 meals Nutrition 0.000 description 2
- 229960001180 norfloxacin Drugs 0.000 description 2
- OGJPXUAPXNRGGI-UHFFFAOYSA-N norfloxacin Chemical compound C1=C2N(CC)C=C(C(O)=O)C(=O)C2=CC(F)=C1N1CCNCC1 OGJPXUAPXNRGGI-UHFFFAOYSA-N 0.000 description 2
- 229930189914 platycodon Natural products 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 230000008673 vomiting Effects 0.000 description 2
- YIWGJFPJRAEKMK-UHFFFAOYSA-N 1-(2H-benzotriazol-5-yl)-3-methyl-8-[2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carbonyl]-1,3,8-triazaspiro[4.5]decane-2,4-dione Chemical compound CN1C(=O)N(c2ccc3n[nH]nc3c2)C2(CCN(CC2)C(=O)c2cnc(NCc3cccc(OC(F)(F)F)c3)nc2)C1=O YIWGJFPJRAEKMK-UHFFFAOYSA-N 0.000 description 1
- NZVZVGPYTICZBZ-UHFFFAOYSA-N 1-benzylpiperidine Chemical compound C=1C=CC=CC=1CN1CCCCC1 NZVZVGPYTICZBZ-UHFFFAOYSA-N 0.000 description 1
- GSDSWSVVBLHKDQ-UHFFFAOYSA-N 9-fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid Chemical compound FC1=CC(C(C(C(O)=O)=C2)=O)=C3N2C(C)COC3=C1N1CCN(C)CC1 GSDSWSVVBLHKDQ-UHFFFAOYSA-N 0.000 description 1
- 241001127714 Amomum Species 0.000 description 1
- 206010008479 Chest Pain Diseases 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- 208000005577 Gastroenteritis Diseases 0.000 description 1
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 description 1
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 206010061245 Internal injury Diseases 0.000 description 1
- AYRXSINWFIIFAE-SCLMCMATSA-N Isomaltose Natural products OC[C@H]1O[C@H](OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O)[C@@H](O)[C@@H](O)[C@@H]1O AYRXSINWFIIFAE-SCLMCMATSA-N 0.000 description 1
- VTAJIXDZFCRWBR-UHFFFAOYSA-N Licoricesaponin B2 Natural products C1C(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2)C(O)=O)C)(C)CC2)(C)C2C(C)(C)CC1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O VTAJIXDZFCRWBR-UHFFFAOYSA-N 0.000 description 1
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 206010059013 Nocturnal emission Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 206010030302 Oliguria Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 206010039424 Salivary hypersecretion Diseases 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 208000032140 Sleepiness Diseases 0.000 description 1
- 206010041349 Somnolence Diseases 0.000 description 1
- 206010041497 Spermatorrhoea Diseases 0.000 description 1
- 208000019229 Spleen disease Diseases 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 1
- DWCSNWXARWMZTG-UHFFFAOYSA-N Trigonegenin A Natural products CC1C(C2(CCC3C4(C)CCC(O)C=C4CCC3C2C2)C)C2OC11CCC(C)CO1 DWCSNWXARWMZTG-UHFFFAOYSA-N 0.000 description 1
- 206010000059 abdominal discomfort Diseases 0.000 description 1
- 208000019790 abdominal distention Diseases 0.000 description 1
- 230000001133 acceleration Effects 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 description 1
- 229940104640 chinese yam extract Drugs 0.000 description 1
- 208000019902 chronic diarrheal disease Diseases 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- HEBKCHPVOIAQTA-NGQZWQHPSA-N d-xylitol Chemical compound OC[C@H](O)C(O)[C@H](O)CO HEBKCHPVOIAQTA-NGQZWQHPSA-N 0.000 description 1
- 230000013872 defecation Effects 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- WQLVFSAGQJTQCK-VKROHFNGSA-N diosgenin Chemical compound O([C@@H]1[C@@H]([C@]2(CC[C@@H]3[C@@]4(C)CC[C@H](O)CC4=CC[C@H]3[C@@H]2C1)C)[C@@H]1C)[C@]11CC[C@@H](C)CO1 WQLVFSAGQJTQCK-VKROHFNGSA-N 0.000 description 1
- WQLVFSAGQJTQCK-UHFFFAOYSA-N diosgenin Natural products CC1C(C2(CCC3C4(C)CCC(O)CC4=CCC3C2C2)C)C2OC11CCC(C)CO1 WQLVFSAGQJTQCK-UHFFFAOYSA-N 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 235000013410 fast food Nutrition 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 150000002212 flavone derivatives Chemical class 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- FTSSQIKWUOOEGC-RULYVFMPSA-N fructooligosaccharide Chemical compound OC[C@H]1O[C@@](CO)(OC[C@@]2(OC[C@@]3(OC[C@@]4(OC[C@@]5(OC[C@@]6(OC[C@@]7(OC[C@@]8(OC[C@@]9(OC[C@@]%10(OC[C@@]%11(O[C@H]%12O[C@H](CO)[C@@H](O)[C@H](O)[C@H]%12O)O[C@H](CO)[C@@H](O)[C@@H]%11O)O[C@H](CO)[C@@H](O)[C@@H]%10O)O[C@H](CO)[C@@H](O)[C@@H]9O)O[C@H](CO)[C@@H](O)[C@@H]8O)O[C@H](CO)[C@@H](O)[C@@H]7O)O[C@H](CO)[C@@H](O)[C@@H]6O)O[C@H](CO)[C@@H](O)[C@@H]5O)O[C@H](CO)[C@@H](O)[C@@H]4O)O[C@H](CO)[C@@H](O)[C@@H]3O)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@@H](O)[C@@H]1O FTSSQIKWUOOEGC-RULYVFMPSA-N 0.000 description 1
- 229940107187 fructooligosaccharide Drugs 0.000 description 1
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 1
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 1
- 229960004949 glycyrrhizic acid Drugs 0.000 description 1
- 239000001685 glycyrrhizic acid Substances 0.000 description 1
- 235000019410 glycyrrhizin Nutrition 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- LTINPJMVDKPJJI-UHFFFAOYSA-N iodinated glycerol Chemical compound CC(I)C1OCC(CO)O1 LTINPJMVDKPJJI-UHFFFAOYSA-N 0.000 description 1
- 229940010454 licorice Drugs 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 1
- 239000008108 microcrystalline cellulose Substances 0.000 description 1
- 229940016286 microcrystalline cellulose Drugs 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 229960001699 ofloxacin Drugs 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 235000021251 pulses Nutrition 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 208000026451 salivation Diseases 0.000 description 1
- 208000027140 splenic disease Diseases 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 208000018556 stomach disease Diseases 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 229940126680 traditional chinese medicines Drugs 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
- A23P10/00—Shaping or working of foodstuffs characterised by the products
- A23P10/20—Agglomerating; Granulating; Tabletting
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/076—Poria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/34—Campanulaceae (Bellflower family)
- A61K36/346—Platycodon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/62—Nymphaeaceae (Water-lily family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/894—Dioscoreaceae (Yam family)
- A61K36/8945—Dioscorea, e.g. yam, Chinese yam or water yam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
- A61K36/8994—Coix (Job's tears)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9064—Amomum, e.g. round cardamom
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Botany (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Medical Informatics (AREA)
- Veterinary Medicine (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Nutrition Science (AREA)
- Medicines Containing Plant Substances (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicinal Preparation (AREA)
Abstract
本发明涉及功能食品或保健食品,具体公开了一种治疗腹泻的组合物及其应用。所述组合物包含以下重量份的组分:人参5‑20份,芡实5‑20份,茯苓5‑15份,山药20‑30份,白扁豆5‑10份,炒莲子5‑10份,薏苡仁10‑20份,砂仁5‑10份,桔梗5‑10份,甘草5‑10份。本发明将所述组分配合共用,通过调节胃肠功能、补脾养胃、除湿止泻达到治疗腹泻的作用,可适用于饮食不规律、快速进餐、以及外食不卫生造成的具有腹泻问题的人群。本发明提供的颗粒剂便于携带、服用快速、口感适中,并有特有的香气。本发明的组合物在应用于治疗腹泻疾病中相比于常规的治疗腹泻的药物具有服用周期短、治愈效果好、无副作用等特点。
Description
技术领域
本发明涉及功能食品或保健食品,具体地说,涉及一种治疗腹泻的组合物及其应用。
背景技术
腹泻俗称“拉肚子”,是指排便次数明显超过平日***衡,造成菌群紊乱,反而使腹泻迁延不愈,或继发二重感染。较西医而言,中草药治疗具有整体调节,辨证施治的优点,无毒副作用更加安全有效。
人参味甘、微苦,性温、平。归脾、肺经、心经。具有大补元气,复脉固脱,补脾益肺,生津,安神的功效。芡实甘、涩、平。归脾、肾经。具有益肾固精,补脾止泻,除湿止带的功效。茯苓甘、淡,平。归心、肺、脾、肾经。具有利水渗湿,健脾,宁心的功效。常用于水肿尿少,痰饮眩悸,脾虚食少,便溏泄泻,心神不安,惊悸失眠。山药甘,平。归脾、肺、肾经。具有补脾养胃,生津益肺,补肾涩精。用于脾虚食少,久泻不止,肺虚喘咳,肾虚遗精,带下,尿频,虚热消渴。白扁豆甘,微温。归脾、胃经。用于脾胃虚弱,食欲不振,大便溏泻,白带过多,暑湿吐泻,胸闷腹胀。炒白扁豆健脾化湿,常用于脾虚泄泻。炒莲子、薏苡仁、砂仁、桔梗以及甘草等中药配伍多具有调节胃肠功能、补脾养胃、除湿止泻的功效。
发明内容
为了解决现有技术中存在的问题,本发明的目的是提供一种治疗腹泻的组合物及其应用。
为了实现本发明目的,本发明的技术方案如下:
本发明首先提供一种治疗腹泻的组合物,包含以下重量份的组分:人参5-20份,芡实5-20份,茯苓5-15份,山药20-30份,白扁豆5-10份,炒莲子5-10份,薏苡仁10-20份,砂仁5-10份,桔梗5-10份,甘草5-10份。
优选地,所述组合物包含以下重量份的组分:人参5-15份,芡实5-15份,茯苓5-10份,山药20-25份,白扁豆5-8份,炒莲子5-9份,薏苡仁10-15份,砂仁5-7份,桔梗5-8份,甘草5-8份。
更为优选地,所述组合物包含以下重量份的组分:人参15份,芡实15份,茯苓12份,山药23份,白扁豆7份,炒莲子9份,薏苡仁15份,砂仁6份,桔梗7份,甘草6份。
上述组合物中:
所述重量份可以是μg、mg、g、kg等医药领域公知的重量单位,也可以是其倍数,如1/10、1/100、10倍、100倍等。
本发明还提供了前述组合物在制备治疗腹泻功能食品或保健食品中的应用。
所述功能食品或保健食品可为医药保健领域常规剂型,如颗粒剂、片剂、胶囊、膏滋、饮料等。
可选/优选地,所述剂型为颗粒剂,包含以下重量份的组分:人参5-20份,芡实5-20份,茯苓5-15份,山药20-30份,白扁豆5-10份,炒莲子5-10份,薏苡仁10-20份,砂仁5-10份,桔梗5-10份,甘草5-10份,益生元50-100份,粘结剂2%-10%(用量为其他组分总重量的2%-10%)。
优选地,所述颗粒剂包含以下重量份的组分:人参5-15份,芡实5-15份,茯苓5-10份,山药20-25份,白扁豆5-8份,炒莲子5-9份,薏苡仁10-15份,砂仁5-7份,桔梗5-8份,甘草5-8份,益生元50-80份,粘结剂2%-8%(用量为其他组分总重量的2%-8%)。
更为优选地,所述颗粒剂包含以下重量份的组分:人参15份,芡实15份,茯苓12份,山药23份,白扁豆7份,炒莲子9份,薏苡仁15份,砂仁6份,桔梗7份,甘草6份,益生元60份,粘结剂5%(用量为其他组分总重量的5%)。
其中,所述益生元为低聚异麦芽糖、低聚果糖或低聚木糖。在本发明的具体实施方式中,所述益生元为低聚异麦芽糖,购自天津益倍元天然产物技术有限公司,其低聚异麦芽糖含量为大于80%。
其中,所述粘结剂为80%(体积分数)的酒精。
本发明进一步提供所述颗粒剂的制备方法:
1)将低聚异麦芽糖过筛,选取60目筛下细粉,按照配比称取人参粉、芡实粉、茯苓粉、山药粉、白扁豆粉、炒莲子粉、薏苡仁粉、砂仁粉、桔梗粉、甘草粉、低聚异麦芽糖细粉,混合均匀;
2)将混合好的细粉加入80%的酒精为粘合剂,制成60目的颗粒,在温度为50℃的条件下进行干燥,干燥时间60分钟,分装,即得。
可选地,所述剂型可为颗粒剂。制备时,可选择使用所述组合物的提取物。本发明所述人参、芡实、茯苓、山药、白扁豆、炒莲子、薏苡仁、砂仁、桔梗和甘草,均可按现有技术常规方法制备提取物,也可市售购得提取物。
本发明涉及到的原料或试剂均为普通市售产品,涉及到的操作如无特殊说明均为本领域常规操作。
在符合本领域常识的基础上,上述各优选条件,可以相互组合,得到具体实施方式。
本发明的有益效果在于:
1、本发明以人参、芡实、茯苓、山药、白扁豆、炒莲子、薏苡仁、砂仁、桔梗、甘草为主要原料,使各种成分合理组方、配合共用,通过调节胃肠功能、补脾养胃、除湿止泻达到治疗腹泻的作用,可适用于饮食不规律、快速进餐、以及外食不卫生造成的具有腹泻问题的人群。
2、本发明提供的颗粒剂便于携带、服用快速、口感适中,并有特有的香气。
3、经过实验,发现服用本发明提供的组合物和颗粒剂的志愿者,腹泻情况得到明显改善。
本发明的组合物在应用于治疗腹泻疾病中相比于常规的治疗腹泻的药物具有服用周期短、治愈效果好、无副作用等特点。
具体实施方式
下面将结合实施例对本发明的优选实施方式进行详细说明。需要理解的是以下实施例的给出仅是为了起到说明的目的,并不是用于对本发明的范围进行限制。本领域的技术人员在不背离本发明的宗旨和精神的情况下,可以对本发明进行各种修改和替换。
下述实施例中所用的材料、试剂等,如无特殊说明,均可从商业途径得到。
颗粒剂制备过程中,如无特殊说明,所使用的手段均为本领域常规的技术手段。
所述人参为种植5年以下人参原粉,购自天津益倍元天然产物技术有限公司;
所述芡实提取物为10:1比例提取物,购自天津益倍元天然产物技术有限公司;
所述茯苓提取物中茯苓多糖含量为30-50%,三萜酸含量为0.5-2%,购自天津益倍元天然产物技术有限公司;
所述山药提取物中薯蓣皂素含量为5-20%,购自天津益倍元天然产物技术有限公司;
所述白扁豆提取物为10:1比例提取物,购自天津益倍元天然产物技术有限公司;
所述炒莲子提取物为10:1比例提取物,购自天津益倍元天然产物技术有限公司;
所述薏苡仁提取物为10:1比例提取物,购自天津益倍元天然产物技术有限公司;
所述砂仁提取物为10:1比例提取物,购自天津益倍元天然产物技术有限公司;
所述桔梗提取物为10:1比例提取物,购自天津益倍元天然产物技术有限公司;
所述甘草提取物中甘草酸含量为2-5%,黄酮含量为2-5%,购自天津益倍元天然产物技术有限公司;
所述低聚异麦芽糖含量为大于80%,购自天津益倍元天然产物技术有限公司。
实施例1
按重量分别称取干燥的人参粉15份,芡实粉15份,茯苓粉12份,山药粉23份,白扁豆粉7份,炒莲子粉9份,薏苡仁粉15份,砂仁粉6份,桔梗粉7份,甘草粉6份,低聚异麦芽糖粉60份,三氯蔗糖0.2%,混合均匀,喷洒粘结剂5%。制成60目的颗粒,在温度为50℃的条件下进行干燥,干燥时间60分钟,分装。
实施例2
按重量分别称取干燥的人参粉10份,芡实10份,茯苓10份,山药30份,白扁豆5份,炒莲子7份,麸炒薏苡仁13份,砂仁8份,桔梗7份,甘草10份,低聚异麦芽糖粉60份,混合均匀,喷洒粘结剂5%。三氯蔗糖0.2%,制成60目的颗粒,在温度为50℃的条件下进行干燥,干燥时间60分钟,分装。
实施例3
按重量分别称取干燥的人参粉5份,芡实5份,茯苓5份,山药20份,白扁豆5份,炒莲子10份,麸炒薏苡仁20份,砂仁10份,桔梗15份,甘草10份,低聚异麦芽糖粉60份,三氯蔗糖0.2%,混合均匀,喷洒粘结剂5%。制成60目的颗粒,在温度为50℃的条件下进行干燥,干燥时间60分钟,分装。
实施例4
按重量分别称取干燥的人参粉7份,芡实7份,茯苓13份,山药25份,白扁豆5份,炒莲子9份,麸炒薏苡仁10份,砂仁9份,桔梗14份,甘草8份,低聚异麦芽糖粉60份,三氯蔗糖0.2%,混合均匀,喷洒粘结剂5%。制成60目的颗粒,在温度为50℃的条件下进行干燥,干燥时间60分钟,分装。
实施例5
按重量分别称取干燥的人参粉15份,芡实提取物15份,茯苓提取物12份,山药提取物23份,白扁豆提取物7份,炒莲子提取物9份,薏苡仁提取物15份,砂仁提取物6份,桔梗提取物7份,甘草提取物6份,低聚异麦芽糖粉60份,微晶纤维素20份,羧甲基淀粉5份,硬脂酸镁1%,混合均匀,直接粉末压片。
实验例1
证明本组合物具有治疗腹泻的实验
1、人群选择:选取25~45岁腹泻患者,男女各60人。
2、实验分组:120名志愿者平均分成6组,这6组志愿者分别服用实施例1-4中的组合物和对比例1、2中的药物。对比例1按使用说明书服用苯已哌啶(治疗急、慢性功能性腹泻),一次1片,一日3次。对比例2按使用说明书服用诺氟沙星(治疗细菌感染引起的腹泻),一次4粒,一日2次。
3、实验方法:服用实施例1-4的志愿者按照剂量服用,每日3餐饭后服用一次,每次5g温水送服,连续服用7天。服用对比例1、2的志愿者按照说明书服用,连续服用7天。
4、实验结果见下表:
完全治愈例 | 显著治愈例 | 基本无效例 | |
实施例1 | 16 | 2 | 2 |
实施例2 | 14 | 3 | 3 |
实施例3 | 11 | 6 | 3 |
实施例4 | 13 | 3 | 4 |
对比例1 | 9 | 6 | 5 |
对比例2 | 7 | 7 | 6 |
从表中的治愈结果可以得出,本发明的实施例1-4治疗腹泻的疗效显著的优于对比例1和对比例2。说明本发明的组合物具有治疗腹泻的作用,并且对于急、慢性功能性腹泻和细菌感染引起的腹泻均有明显效果。同时服用实施例1-4的患者没有出现对比例1、2中患者出现的腹部不适、恶心呕吐、头晕嗜睡等副作用。说明本发明的组合物安全有效、无副作用。
虽然,上文中已经用一般性说明及具体实施方案对本发明作了详尽的描述,但在本发明基础上,可以对之作一些修改或改进,这对本领域技术人员而言是显而易见的。因此,在不偏离本发明精神的基础上所做的这些修改或改进,均属于本发明要求保护的范围。
Claims (2)
1.一种治疗腹泻的药物制剂,其特征在于,所述制剂为颗粒剂,所述颗粒剂的原料包含治疗腹泻的组合物,所述组合物由以下重量份的组分组成:人参15份,芡实15份,茯苓12份,山药23份,白扁豆7份,炒莲子9份,薏苡仁15份,砂仁6份,桔梗7份,甘草6份;
所述颗粒剂的原料还包括益生元60份和重量为前述组分总重量5%的粘结剂。
2.根据权利要求1所述的制剂,其特征在于,其制备方法包括如下步骤:
1)将益生元过筛,选取60目筛下细粉,所述益生元为低聚异麦芽糖,按照配比称取人参粉、芡实粉、茯苓粉、山药粉、白扁豆粉、炒莲子粉、薏苡仁粉、砂仁粉、桔梗粉、甘草粉、低聚异麦芽糖细粉,混合均匀;
2)将混合好的细粉加入粘结剂,制成60目的颗粒,在温度为50℃的条件下进行干燥,干燥时间60分钟,分装,即得。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710743148.8A CN107432472B (zh) | 2017-08-25 | 2017-08-25 | 一种治疗腹泻的组合物及其应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710743148.8A CN107432472B (zh) | 2017-08-25 | 2017-08-25 | 一种治疗腹泻的组合物及其应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN107432472A CN107432472A (zh) | 2017-12-05 |
CN107432472B true CN107432472B (zh) | 2020-12-01 |
Family
ID=60460591
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201710743148.8A Active CN107432472B (zh) | 2017-08-25 | 2017-08-25 | 一种治疗腹泻的组合物及其应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN107432472B (zh) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108261520A (zh) * | 2018-03-09 | 2018-07-10 | 河南荟仁堂生物科技有限公司 | 对症肠炎的药剂及其制备方法 |
CN110326777A (zh) * | 2019-06-26 | 2019-10-15 | 洛阳深山生物科技有限公司 | 具有补脾益气、调理肠胃功能的魔芋代餐粥及其制备方法 |
CN113068833A (zh) * | 2021-03-10 | 2021-07-06 | 苏州雷允上健康养生有限公司 | 一种具有健脾祛湿、调节胃肠道功能的保健食品及其制备方法和应用 |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102085327A (zh) * | 2009-12-02 | 2011-06-08 | 程兴顺 | 一种参苓白术胶囊 |
CN102309716A (zh) * | 2011-09-30 | 2012-01-11 | 蚌埠丰原涂山制药有限公司 | 一种治疗带下症的中药组合物及其制备方法 |
CN103893661A (zh) * | 2012-12-30 | 2014-07-02 | 戴绍波 | 一种治疗慢性腹泻的中药组方 |
CN104001095A (zh) * | 2014-06-06 | 2014-08-27 | 济南科纳信息科技有限公司 | 一种治疗腹泻的中药组合物 |
CN104783168A (zh) * | 2015-05-05 | 2015-07-22 | 南昌康泰利保健品有限公司 | 一种治疗腹泻的复配营养粉 |
CN106690309A (zh) * | 2016-12-27 | 2017-05-24 | 天津市康世生物技术有限公司 | 一种具有缓解焦虑、改善睡眠作用的组合物及其应用 |
-
2017
- 2017-08-25 CN CN201710743148.8A patent/CN107432472B/zh active Active
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102085327A (zh) * | 2009-12-02 | 2011-06-08 | 程兴顺 | 一种参苓白术胶囊 |
CN102309716A (zh) * | 2011-09-30 | 2012-01-11 | 蚌埠丰原涂山制药有限公司 | 一种治疗带下症的中药组合物及其制备方法 |
CN103893661A (zh) * | 2012-12-30 | 2014-07-02 | 戴绍波 | 一种治疗慢性腹泻的中药组方 |
CN104001095A (zh) * | 2014-06-06 | 2014-08-27 | 济南科纳信息科技有限公司 | 一种治疗腹泻的中药组合物 |
CN104783168A (zh) * | 2015-05-05 | 2015-07-22 | 南昌康泰利保健品有限公司 | 一种治疗腹泻的复配营养粉 |
CN106690309A (zh) * | 2016-12-27 | 2017-05-24 | 天津市康世生物技术有限公司 | 一种具有缓解焦虑、改善睡眠作用的组合物及其应用 |
Non-Patent Citations (2)
Title |
---|
参苓白术散在儿科临床中的运用;李琳;《时珍国医国药》;20041231;第15卷(第8期);第523-524页 * |
李琳.参苓白术散在儿科临床中的运用.《时珍国医国药》.2004,第15卷(第8期),第523-524页. * |
Also Published As
Publication number | Publication date |
---|---|
CN107432472A (zh) | 2017-12-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101972338B (zh) | 一种治疗小儿上呼吸道感染的中药制剂及其制备方法 | |
CN107432472B (zh) | 一种治疗腹泻的组合物及其应用 | |
CN112546167A (zh) | 一种具有健脾利湿功能的中药组合物及其制备方法和应用 | |
KR100813187B1 (ko) | 비만 예방 및 억제능 갖는 한약재 추출 조성물 | |
CN103933193B (zh) | 一种天然植物类生物抗癌药物 | |
CN103830674B (zh) | 一种治疗脂肪瘤的药物组合物及制备方法和用途 | |
CN104998162A (zh) | 一种治疗咳嗽的药物及其制备方法 | |
CN105125789A (zh) | 治疗胃痛的健脾和胃制剂及制备方法 | |
CN107362301B (zh) | 香苓开胃颗粒 | |
CN101991773B (zh) | 一种枇杷肉提炼成枇杷膏及其制备方法 | |
CN104984097A (zh) | 一种治疗原发性高血压的中药制剂及其用途 | |
CN102366537A (zh) | 一种治疗肺燥咳嗽的中药制剂及制备方法 | |
CN115845009B (zh) | 一种治疗脾虚泄泻的脐灸药粉及其应用 | |
CN109316540A (zh) | 一种健脾和胃穴位贴及其制备方法 | |
CN101695534B (zh) | 治疗乳腺疾病的中成药 | |
CN106361982A (zh) | 一种治疗糖尿病的药食两用中药制剂及其制备方法 | |
CN106692431A (zh) | 一种治疗和预防鸭霍乱的药物及其制备方法 | |
CN104666460A (zh) | 一种具祛痤疮功效的组合物及其应用、制剂 | |
CN105193889A (zh) | 一种制人参花的制剂及制备方法 | |
CN104353053A (zh) | 一种用于治疗猪支原体肺炎的中药组合物及其制备方法 | |
CN102652827B (zh) | 一种治疗癌症的药物和制备方法 | |
CN111012828A (zh) | 健脾消食的中药组合物及其在制备健脾消食药物中的应用 | |
CN118044611A (zh) | 一种清肺护肺的营养品 | |
CN103789172A (zh) | 一种酸浆强心健脾酒及生产方法 | |
CN116850258A (zh) | 一种具有止吐作用的中药组合物及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: A composition for treating diarrhea and its application Effective date of registration: 20231009 Granted publication date: 20201201 Pledgee: China Construction Bank Corporation Tianjin Development Branch Pledgor: TIANJIN KANGSHI BIOTECHNOLOGY Co.,Ltd. Registration number: Y2023980059989 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right |